Dr. David Hwang has a bachelors and doctorate in Bioengineering from the University of Maryland. He has worked as a Biomedical Engineer in the US Food and Drug Administration’s Office of Health Technology 6 (OHT6): Orthopedic Devices, housed in the Center for Devices and Radiologic Health (CDRH) for over 9 years. He is a reviewer in the Division of Spinal Devices (DHT6B), with primary responsibilities being the premarket review of spinal devices. He is also heavily involved with the Additive Manufacturing Working Group which is leading efforts across the Agency to evaluate medical devices and other regulated medical products with this rapidly growing technology. These efforts include guidance and standards development, device review harmonization, and regulatory science with the intent to foster innovative and high quality products that are safe and effective.